Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 2/20 | 0.54 |
| ▸ | CDC25B | P30305 | 1/20 | 0.53 |
| ▸ | VDR | P11473 | 8/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8971279 | 0.84 | VDR (0.57) | CDC25ACDC25BVDRHDAC3HDAC6 | |
| SCHEMBL3681975 | 0.81 | HDAC6 (0.62) | CDC25AVDRHDAC3HDAC6HDAC2 | |
| SCHEMBL8610933 | 0.81 | HDAC6 (0.62) | CDC25AVDRHDAC3HDAC6HDAC2 | |
| SCHEMBL7545052 | 0.76 | VDR (0.56) | CDC25AVDR | |
| SCHEMBL3679281 | 0.76 | VDR (0.83) | VDR | |
| SCHEMBL7544641 | 0.75 | CDC25A (0.53) | CDC25ACDC25BVDRHDAC3HDAC6 | |
| SCHEMBL7544638 | 0.75 | CDC25A (0.53) | CDC25ACDC25BVDRHDAC3HDAC6 | |
| SCHEMBL13532024 | 0.75 | HDAC6 (0.81) | VDRHDAC3HDAC6HDAC2 | |
| SCHEMBL15803031 | 0.74 | CDC25A (0.66) | CDC25ACDC25BVDRHDAC3HDAC6 | |
| SCHEMBL17302251 | 0.74 | CDC25A (0.66) | CDC25ACDC25BVDRHDAC3HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0696275-A1 | VITAMIN D AMIDE DERIVATIVES | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY (US) | 1996-02-14 | — | — | EP | disclosed |
| WO-1994026707-A1 | VITAMIN D AMIDE DERIVATIVES | HOLMES, MICHAEL, JOHN (GB) | 1994-11-24 | — | — | WO | disclosed |